4.7 Article

Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

FoxM1: Repurposing an oncogene as a biomarker

Deeptashree Nandi et al.

SEMINARS IN CANCER BIOLOGY (2018)

Article Oncology

Cancer Statistics, 2018

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Article Oncology

FOXO family in regulating cancer and metabolism

Jian Ma et al.

SEMINARS IN CANCER BIOLOGY (2018)

Review Oncology

FoxO transcription factors in cancer metabolism

Raj Kumar Yadav et al.

SEMINARS IN CANCER BIOLOGY (2018)

Review Biochemistry & Molecular Biology

Critical role of FOXO3a in carcinogenesis

Ying Liu et al.

MOLECULAR CANCER (2018)

Article Biochemistry & Molecular Biology

Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells

K. Tominaga et al.

ONCOGENE (2017)

Article Biochemistry & Molecular Biology

FOXO3 is essential for CD44 expression in pancreatic cancer cells

M. Kumazoe et al.

ONCOGENE (2017)

Article Biochemistry & Molecular Biology

The FOXO3/PGC-1β signaling axis is essential for cancer stem cell properties of pancreatic ductal adenocarcinoma

Motofumi Kumazoe et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Review Oncology

DNA Methylation in Cancer and Aging

Michael Klutstein et al.

CANCER RESEARCH (2016)

Article Multidisciplinary Sciences

NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance

Ching-Feng Chiu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Gastroenterology & Hepatology

Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features

Dragana Kopanja et al.

JOURNAL OF HEPATOLOGY (2015)

Review Oncology

A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms

Monica Cojoc et al.

SEMINARS IN CANCER BIOLOGY (2015)

Article Multidisciplinary Sciences

DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis

Rajneesh Pathania et al.

NATURE COMMUNICATIONS (2015)

Article Gastroenterology & Hepatology

The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma

Shu-Bin Gao et al.

JOURNAL OF HEPATOLOGY (2014)

Review Biochemistry & Molecular Biology

Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance

Hariharan Easwaran et al.

MOLECULAR CELL (2014)

Article Biochemistry & Molecular Biology

FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis

K. Levanon et al.

ONCOGENE (2014)

Review Biochemistry & Molecular Biology

Targeting cancer stem cells to suppress acquired chemotherapy resistance

S. J. Vidal et al.

ONCOGENE (2014)

Review Oncology

FOXM1: A key oncofoetal transcription factor in health and disease

Laura Bella et al.

SEMINARS IN CANCER BIOLOGY (2014)

Review Oncology

DNA methyltransferases: a novel target for prevention and therapy

Dharmalingam Subramaniam et al.

FRONTIERS IN ONCOLOGY (2014)

Review Biochemistry & Molecular Biology

The roles of FOXM1 in pancreatic stem cells and carcinogenesis

Ming Quan et al.

MOLECULAR CANCER (2013)

Article Multidisciplinary Sciences

Foxo3a Expression Is a Prognostic Marker in Breast Cancer

Ying Jiang et al.

PLOS ONE (2013)

Review Oncology

Forkhead box proteins: tuning forks for transcriptional harmony

Eric W. -F. Lam et al.

NATURE REVIEWS CANCER (2013)

Article Biochemistry & Molecular Biology

FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer

C. T. Karadedou et al.

ONCOGENE (2012)

Article Oncology

FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer

Hany Onsy Habashy et al.

BREAST CANCER RESEARCH AND TREATMENT (2011)

Article Cell Biology

Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia

Sylvain Thepot et al.

CELL CYCLE (2011)

Article Oncology

Highly Phosphorylated FOXO3A Is an Adverse Prognostic Factor in Acute Myeloid Leukemia

Steven M. Kornblau et al.

CLINICAL CANCER RESEARCH (2010)

Article Biochemical Research Methods

ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays

Yifang Hu et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2009)

Article Oncology

Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer

Ursula B. McGovern et al.

MOLECULAR CANCER THERAPEUTICS (2009)

Article Multidisciplinary Sciences

The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations

Anna Dubrovska et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Cell Biology

ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

Jer-Yen Yang et al.

NATURE CELL BIOLOGY (2008)

Article Cell & Tissue Engineering

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Christophe Ginestier et al.

CELL STEM CELL (2007)

Article Multidisciplinary Sciences

Prospective identification of tumorigenic breast cancer cells

M Al-Hajj et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Biochemistry & Molecular Biology

Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a)

A Brunet et al.

MOLECULAR AND CELLULAR BIOLOGY (2001)